Globus Medical (GMED) Capital Expenditures (2011 - 2026)

Globus Medical's Capital Expenditures history runs 16 years deep, the most recent figure standing at $39.6 million for Q1 2026.

• Quarterly Capital Expenditures rose 9.73% year-over-year to $39.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168.2 million (up 900.18% YoY) and the FY2025 annual result came in at $164.7 million, up 1674.37% from the prior year.
• Capital Expenditures was $39.6 million for Q1 2026 at Globus Medical, down from $46.2 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $105.0 million in Q3 2025 and bottomed at -$89.0 million in Q4 2024.
• A 5-year average of $21.5 million and a median of $23.8 million in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures soared 2490.29% — and 2024, when it slumped 489.13%.
• Globus Medical's Capital Expenditures stood at $18.3 million in 2022, then grew by 24.76% to $22.9 million in 2023, then slumped by 489.13% to -$89.0 million in 2024, then jumped by 151.89% to $46.2 million in 2025, then dropped by 14.25% to $39.6 million in 2026.
• Business Quant data shows GMED's Capital Expenditures at $39.6 million in Q1 2026, $46.2 million in Q4 2025, and $105.0 million in Q3 2025.